Tyrosine hydroxylase deficiency: Clinical manifestations of catecholamine insufficiency in infancy
- 7 February 2002
- journal article
- case report
- Published by Wiley in Movement Disorders
- Vol. 17 (2) , 354-359
- https://doi.org/10.1002/mds.10095
Abstract
Inborn errors of catecholamine biosynthesis are rare but of great interest as they are genetic disorders, and in some, treatment may completely reverse severe neurological abnormalities. They also provide insights into the action of the biogenic amines in the developing brain. We describe the clinical course of an infant with tyrosine hydroxylase (TOH) deficiency over a 30‐month period. The parents are consanguineous, and genetic analysis revealed the infant to be homozygous for the common G698A mutation in the TOH gene. TOH deficiency can be seen as a model of pure catecholamine deficiency. Experimental evidence, reports of other disorders of biogenic amines, and our experience with this infant suggest that the symptoms of catecholamine deficiency in infancy can be broadly subdivided. Signs of dopamine deficiency include tremor, hypersensitivity to levadopa (L‐dopa) therapy, oculogyric crises, akinesia, rigidity, and dystonia. Manifestations of norepinephrine deficiency include ptosis, miosis, profuse oropharyngeal secretions, and postural hypotension. Hypersensitivity to L‐dopa was a particular management problem in this infant. © 2002 Movement Disorder Society.Keywords
This publication has 30 references indexed in Scilit:
- l -dopa–responsive infantile hypokinetic rigid parkinsonism due to tyrosine hydroxylase deficiencyNeurology, 2000
- Tyrosine hydroxylase deficiency with severe clinical course: Clinical and biochemical investigations and optimization of therapyThe Journal of Pediatrics, 2000
- Four novel mutations in the Tyrosine Hydroxylase gene in patients with infantile parkinsonismAnnals of Human Genetics, 2000
- A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC)Journal of Inherited Metabolic Disease, 1999
- A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch populationHuman Genetics, 1998
- Cerebrospinal Fluid Investigations for Neurometabolic DisordersNeuropediatrics, 1998
- Oral phenylalanine loading in dopa‐responsive dystoniaNeurology, 1997
- Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase geneHuman Molecular Genetics, 1996
- Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase geneHuman Molecular Genetics, 1995
- Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal developmentNature, 1995